Please login to the form below
The Medicines Company
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of The Medicines Company's 2013 cardiovasular sales performance.
Cortellis Drugs to Watch in 2020 report
The three from this year’s list are: Valrox, which if approved, would become the first gene therapy for any form of haemophilia; Inclisiran, from The Medicines Company, which could become ... 8. Inclisiran from The Medicines Company (now a Novartis
Novartis plans inclisiran trial in the UK
The announcement was made on the same day that the company officially opened its new headquarters in White City, London. ... Novartis acquired inclisiran from The Medicines Company, after a completing a $9.7bn takeover of the company.
Cosentyx, Entresto drive topline growth for Novartis in Q4
According to the company, the momentum of the neprilysin inhibitor was driven by a higher demand in ambulatory settings. ... These new drugs are expected to continue to drive growth into 2020 – newly acquired cholesterol drug inclisiran, gained from
Novartis links up with NHS for speedy access to cholesterol drug inclisiran
Novartis gained inclisiran from its $9.7bn acquisition of the drug's developer The Medicines Company, which completed last week. ... watchdog NICE once it receives approval from the European Medicines Agency (EMA).
Novartis picks up inclisiran after completion of MedCo acquisition
If approved could become blockbuster cholesterol treatment. Novartis has added potential blockbuster cholesterol treatment inclisiran to its pipeline following the completion of its $9.7bn acquisition of The Medicines Company. . ... 2021. “Acquiring
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Gilead agrees $21bn buyout of Immunomedics
- New medical communications agency BOLDSCIENCE launches
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- Moderna inks R&D agreements with Vertex and Chiesi
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Could formulary intelligence be your brand differentiator?
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Porterhouse Medical strengthens its senior management team
PMHub
Fishawack Group of Companies
The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...
Latest intelligence
- Could formulary intelligence be your brand differentiator?
- Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
Quick links
Infographics
